Literature DB >> 8768726

A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia.

S Hoshida1, N Yamashita, J Igarashi, M Nishida, M Hori, T Kuzuya, M Tada.   

Abstract

We evaluated the propagation of myocardial injury in a model of coronary artery occlusion and reperfusion in control and hypercholesterolemic rabbits. This was done by examining the differences in the infarct size and in the extent of leukocyte accumulation resulting from coronary artery occlusion (30 min) followed by reperfusion (2 or 48 hr) in rabbits fed 1% cholesterol for 4 days vs. controls not fed cholesterol. There was no significant difference in the infarct size in the 2-hr (45.7 +/- 6.7%, n = 8) vs. 48-hr (48.8 +/- 5.8%, n = 9) models of reperfusion in control rabbits. However, infarct size in the cholesterol-fed rabbits at 2 hr (64.0 +/- 4.1%, n = 6) or 48 hr (72.3 +/- 3.0%, n = 8) of reperfusion significantly exceeded that in the corresponding controls (P < .05). The infarct in cholesterol-fed rabbits at 2 hr of reperfusion was smaller than that at 48 hr of reperfusion, but not significantly. Treatment with S-nitroso-N-acetylpenicillamine, a nitric oxide donor, effectively reduced the size of infarct in the cholesterol-fed rabbits. However, treatment with N-acetylpenicillamine had no infarct-limiting effect. When we evaluated the extent of leukocyte accumulation in the ischemic myocardium, as assessed by myeloperoxidase activity, a positive correlation was observed between myeloperoxidase activity and infarct size at 48 hr of reperfusion. Results indicate that the propagation of myocardial ischemia and reperfusion injury in acutely hypercholesterolemic rabbits differed from that in controls. An exogenous nitric oxide donor effectively reduced the size of infarct associated with the reduction in the accumulation of leukocytes 48 hr after reperfusion, which suggests that a reduction in the production of endogenous nitric oxide during ischemia and reperfusion may aggravate the severity of myocardial injury in acutely hypercholesterolemic rabbits.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8768726

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

Review 1.  Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia.

Authors:  Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 2.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

Review 3.  Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Authors:  Ioanna Andreadou; Efstathios K Iliodromitis; Antigone Lazou; Anikó Görbe; Zoltán Giricz; Rainer Schulz; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2017-02-08       Impact factor: 8.739

4.  Effect of zinc supplements in the attenuated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart.

Authors:  Sunil Kumar Kansal; Uma Jyoti; Samridhi Sharma; Arun Kaura; Rahul Deshmukh; Sandeep Goyal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-03-07       Impact factor: 3.000

5.  Syntaxin 1A mediates isoflurane but not hypoxia preconditioning-induced alleviation of hypoxia-reoxygenation injury in rat cardiomyocytes.

Authors:  Meng Liu; Hao Zhang; Qingqing Zhang; Caiguo Huang; Xueyin Shi
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

6.  Hypercholesterolemia abrogates an increased resistance of diabetic rat hearts to ischemia-reperfusion injury.

Authors:  A Adameová; M Kuzelová; E Andelová; V Faberová; D Pancza; P Svec; A Ziegelhöffer; T Ravingerová
Journal:  Mol Cell Biochem       Date:  2006-08-10       Impact factor: 3.396

7.  Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation.

Authors:  Lu-Lu Yan; Wei-Yang Zhang; Xiao-Hong Wei; Li Yan; Chun-Shui Pan; Yang Yu; Jing-Yu Fan; Yu-Ying Liu; Hua Zhou; Jing-Yan Han; Xin-Sheng Yao
Journal:  Front Physiol       Date:  2018-04-04       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.